Benefits of thymectomy in treating myasthenia gravis discussed - dofaq.co
Benefits of thymectomy in treating myasthenia gravis discussed
University at Buffalo Reporter - 08 Jul 2024
The first-ever randomized study of the removal of the thymus gland in treating myasthenia gravis was conducted in 2016. Led by Gil I. Wolfe, ...
Expanding Myasthenia Gravis Treatment With Newly Approved Therapy Nipocalimab: Nicholas J. Silvestri, MD, FAAN
Neurology live - 06 May 2025
Expanding Myasthenia Gravis Treatment With Newly Approved Therapy Nipocalimab: Nicholas J. Silvestri, MD, FAAN ...
Highlights in Myasthenia Gravis From AAN 2025
Medscape - 30 Apr 2025
Highlights in Myasthenia Gravis From AAN 2025 ...
Unusual presentations of myasthenia gravis and misdiagnosis
Nature - 04 Mar 2025
Unusual presentations of myasthenia gravis and misdiagnosis ...
Enrollment complete in Phase 2 trial testing DNTH103 for gMG
Myasthenia Gravis News - 06 May 2025
Enrollment complete in Phase 2 trial testing DNTH103 for gMG ...
J&J’s IMAAVY Approved by FDA for Treatment of Generalized Myasthenia Gravis
Contract Pharma - 01 May 2025
J&J’s IMAAVY Approved by FDA for Treatment of Generalized Myasthenia Gravis ...
Johnson & Johnson receives FDA approval for IMAAVY™ (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG)
PR Newswire - 30 Apr 2025
Johnson & Johnson receives FDA approval for IMAAVY™ (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG) ...
Myasthenia gravis with double-seropositive acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies combined with muscle atrophy: a case report and literature review
Frontiers - 27 Apr 2025
Myasthenia gravis with double-seropositive acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies combined with muscle atrophy: a case report and literature review ...
Early Diagnosis Vital to Myasthenia Gravis Treatment: Richard J. Nowak, MD, MS
AJMC - 25 Apr 2025
Early Diagnosis Vital to Myasthenia Gravis Treatment: Richard J. Nowak, MD, MS ...
Imaavy Approved for Generalized Myasthenia Gravis
Medical Professionals Reference - 30 Apr 2025
Imaavy Approved for Generalized Myasthenia Gravis ...
FDA Approves New Monoclonal Antibody for Myasthenia Gravis
Medscape - 30 Apr 2025
FDA Approves New Monoclonal Antibody for Myasthenia Gravis ...
Efficacy and safety of rituximab in anti-MuSK myasthenia Gravis: a systematic review and meta-analysis
Nature - 28 Feb 2025
Efficacy and safety of rituximab in anti-MuSK myasthenia Gravis: a systematic review and meta-analysis ...
FDA Approves FcRn Blocker Nipocalimab for Broad Forms of Generalized Myasthenia Gravis
Neurology live - 30 Apr 2025
FDA Approves FcRn Blocker Nipocalimab for Broad Forms of Generalized Myasthenia Gravis ...
Mortality Risk in Patients with Myasthenia Gravis
Frontiers - 27 Apr 2025
Mortality Risk in Patients with Myasthenia Gravis ...
AAN 2025: Advancing Personalized Care in Myasthenia Gravis
Medscape - 28 Apr 2025
AAN 2025: Advancing Personalized Care in Myasthenia Gravis ...
Serum fibrinogen is not elevated in patients with myasthenia gravis
Nature - 15 Apr 2025
Serum fibrinogen is not elevated in patients with myasthenia gravis ...
Factors associated with increased severity of generalized myasthenia gravis among patients in the United States and Europe
Nature - 01 Apr 2025
Factors associated with increased severity of generalized myasthenia gravis among patients in the United States and Europe ...
Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience
Frontiers - 13 Apr 2025
Complement inhibitor therapy in thymoma-associated myasthenia gravis : a real-world experience ...
Myasthenia gravis following statin therapy: evidence from target trial emulation and self-controlled case series study
Nature - 28 Nov 2024
Myasthenia gravis following statin therapy: evidence from target trial emulation and self-controlled case series study ...
Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction
Nature - 13 Nov 2024
Genome-wide meta-analysis of myasthenia gravis uncovers new loci and provides insights into polygenic prediction ...